1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 110 results.

CLL - 009

Application of CRISPR-Cas9 Technology in the Treatment of Chronic Lymphocytic Leukemia with P53 Gene Mutations

Aurelian Udristioiu

Poster Presenter: Aurelian Udristioiu

CLL - 010

Abnormal Apoptosis of Autoimmunity From Chronic Lymphocytic Leukemia

Aurelian Udristioiu

Poster Presenter: Aurelian Udristioiu

CLL - 046

Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017-2021)

Toluwani Balogun

Poster Presenter: Toluwani Balogun

Thumbnail for Frequency of Chromosome 11q22-q23 Deletion in Pakistani Patients With Chronic Lymphocytic Leukemia: A Single-Center Institutional Study

CLL - 065

Frequency of Chromosome 11q22-q23 Deletion in Pakistani Patients With Chronic Lymphocytic Leukemia: A Single-Center Institutional Study

Shayan Ashfaq

Poster Presenter: Shayan Ashfaq

Thumbnail for Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Predict Response, Minimal Residual Disease, and Survival and Guide Treatment Choice in Newly Diagnosed Chronic Lymphocytic Leukemia Patients

CLL - 074

Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Predict Response, Minimal Residual Disease, and Survival and Guide Treatment Choice in Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Omar Ali Elbaioumi

Poster Presenter: Omar Ali Elbaioumi

CLL - 083

Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

CLL - 1019

Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

CLL - 1026

Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

Chinenye Okafor

Poster Presenter: Chinenye Okafor

$Thumbnail for Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis$

CLL - 1061

Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis

Subodh Mathew

Poster Presenter: Subodh Mathew